EAM Investors, LLC - ADMA BIOLOGICS INC ownership

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,462,383
+6.2%
967,146
+9.4%
0.67%
+10.6%
Q2 2023$3,261,377
-4.9%
883,842
-14.7%
0.60%
-10.3%
Q1 2023$3,428,339
-49.5%
1,035,752
-40.8%
0.67%
-52.1%
Q4 2022$6,788,440
+95.7%
1,749,598
+22.6%
1.40%
+86.3%
Q3 2022$3,468,000
+40.3%
1,427,160
+14.3%
0.75%
+25.0%
Q2 2022$2,471,0001,248,1360.60%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 1,433,304$6,464,00099.88%
Broadfin Capital, LLC 3,249,829$14,657,0002.31%
Stonepine Capital Management, LLC 831,731$3,751,0002.28%
Aisling Capital LLC 3,608,171$16,273,0002.14%
Consonance Capital Management LP 4,249,234$19,164,0001.24%
MORGENS WATERFALL VINTIADIS & CO INC 375,000$1,691,0001.20%
Perceptive Advisors 6,521,102$29,410,0000.77%
PURA VIDA INVESTMENTS, LLC 325,000$1,466,0000.59%
683 Capital Management, LLC 885,000$3,991,0000.27%
ARDSLEY ADVISORY PARTNERS LP 80,000$361,0000.05%
View complete list of ADMA BIOLOGICS INC shareholders